APA (7th ed.) Citation

Herfarth, K., Scholz, C. W., Hübel, K., Wirths, S., Buske, C., von Tresckow, J., . . . Thalmann, P. (2025). 110 | HIGH PFS WITH LOW INFIELD RECURRENCES AFTER LOW DOSE RADIOTHERAPY AND OBINUTUZUMAB IN EARLY STAGE NODAL FOLLICULAR LYMPHOMA: FINAL RESULTS OF THE GAZAI STUDY (GLA 2018‐3). Hematological oncology, 43, 1. https://doi.org/10.1002/hon.70093_110

Chicago Style (17th ed.) Citation

Herfarth, K., et al. "110 | HIGH PFS WITH LOW INFIELD RECURRENCES AFTER LOW DOSE RADIOTHERAPY AND OBINUTUZUMAB IN EARLY STAGE NODAL FOLLICULAR LYMPHOMA: FINAL RESULTS OF THE GAZAI STUDY (GLA 2018‐3)." Hematological Oncology 43 (2025): 1. https://doi.org/10.1002/hon.70093_110.

MLA (9th ed.) Citation

Herfarth, K., et al. "110 | HIGH PFS WITH LOW INFIELD RECURRENCES AFTER LOW DOSE RADIOTHERAPY AND OBINUTUZUMAB IN EARLY STAGE NODAL FOLLICULAR LYMPHOMA: FINAL RESULTS OF THE GAZAI STUDY (GLA 2018‐3)." Hematological Oncology, vol. 43, 2025, p. 1, https://doi.org/10.1002/hon.70093_110.